Influenza virus vaccine (ID Biomedical Corporation/GlaxoSmithKline)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInfluenza virus vaccine (ID Biomedical Corporation/GlaxoSmithKline)
Drug Alias NameFlulavalSPD-707GSK-1536489AGSK-1557482A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza A virus infectionsInfluenza, HumanInfluenza B virus infection
Global Approved IndicationsInfluenza A virus infectionsInfluenza, HumanInfluenza B virus infection
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2006/10/05
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsInfluenza A virus infectionsInfluenza, HumanInfluenza B virus infection
Inactive IndicationsN/A

Other Information

ATC CodeJ07BB01
Related LinksN/A